
-
2016
Company Description
Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
Repare has developed and deployed a proprietary, high-throughput, genomic synthetic lethal screening platform that harnesses the precision and power of CRISPR/Cas9 genome editing, high-resolution protein crystallography and computational biology, and the unprecedented ability to exploit DNA Damage Repair (DDR) defects found across virtually all cancers.
-
Manufacturer:
Science and Engineering -
Formed:
2016 -
Founders:
Agnel Sfeir -
Company Website:
-
Company E-mail:
-
Company Address:
7210 Frederick-Banting,, Suite 100, St-LaurentQCCanada -
CEO:
- Agnel Sfeir
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits